Taken together, these results proved that CLS treatment could effectively inhibit the growth of NCI-H1975 tumor xenografts in a dose-dependent manner through cytokine-cytokine receptor interaction, PIK-Akt, MAPK signaling pathways. Here, AKT1 is linked to neoplasm.